CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
ABDALA-Intervention	27/03/2021	Registered
Evaluation of the safety and immunogenicity of the vaccine candidate "ABDALA" in children and adolescents	01/07/2021	Registered
MEÑIQUE Study	03/09/2021	Registered
Jusvinza in rheumatoid arthritis	20/04/2022	Registered
Nasal recombinant human interferon alfa-2b in ARI	06/12/2022	Registered
Nasalferon in ARI	29/07/2022	Registered
Exploratory study to evaluate the effect and safety of CIGB 500 in seriously ill patients with shock	06/07/2023	Registered
Efficacy and safety of Jusvinza treatment in patients with acute respiratory distress syndrome. Phase II/III	24/04/2023	Registered
Evaluation of the effect and safety of a booster dose of Abdala against COVID-19.	06/09/2024	Registered
Nasalferon in respiratory infections in adults. Phase 3 clinical trial.	13/02/2025	Registered
Safety and therapeutic effect of administration of Jusvinza in the post-acute stage of Chikungunya infection	19/11/2025	Registered
Safety and therapeutic effect of administration of Jusvinza in the chronic stage of Chikungunya infection	17/11/2025	Registered
Growth hormone-releasing peptide in sepsis-induced myocardial dysfunction.	28/03/2026	Registered
Effectiveness and Safety of Jusvinza in Patients with Chikungunya	31/03/2026	Registered